Related references
Note: Only part of the references are listed.Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
Cornelia L. Trimble et al.
LANCET (2015)
p16INK4a/Ki-67 co-expression specifically identifies transformed cells in the head and neck region
Elena-Sophie Prigge et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
The clinical impact of using p16INK4a immunochemistry in cervical histopathology and cytology: An update of recent developments
Christine Bergeron et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Depletion of the cdk Inhibitor p16INK4a Differentially Affects Proliferation of Established Cervical Carcinoma Cells
Alexander Pauck et al.
JOURNAL OF VIROLOGY (2014)
The role of senescent cells in ageing
Jan M. van Deursen
NATURE (2014)
Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
Julia Scheiermann et al.
VACCINE (2014)
Therapeutic Vaccine Strategies against Human Papillomavirus
Hadeel Khallouf et al.
VACCINES (2014)
HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
Mariette I. E. van Poelgeest et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines
Margaret E. McLaughlin-Drubin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Immuno-oncology: understanding the function and dysfunction of the immune system in cancer
O. J. Finn
ANNALS OF ONCOLOGY (2012)
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions
Peggy J. de Vos van Steenwijk et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Biomarkers for cervical cancer screening: the role of p16INK4a to highlight transforming HPV infections
Magnus von Knebel Doeberitz et al.
EXPERT REVIEW OF PROTEOMICS (2012)
Evaluation of cervical cone biopsies for coexpression of p16INK4a and Ki-67 in epithelial cells
Miriam Reuschenbach et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Global Burden of Human Papillomavirus and Related Diseases
David Forman et al.
VACCINE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming
Margaret E. McLaughlin-Drubin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Host Factors in HPV-related Carcinogenesis: Cellular Mechanisms Controlling HPV Infections
Magnus von Knebel Doeberitz et al.
ARCHIVES OF MEDICAL RESEARCH (2009)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.
Gemma G. Kenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Papillomaviruses in the causation of human cancers - a brief historical account
Harald zur Hausen
VIROLOGY (2009)
Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows lowtoxicity and robust immunogenicity
Gemma G. Kenter et al.
CLINICAL CANCER RESEARCH (2008)
Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers
Miriam Reuschenbach et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Cellular senescence in cancer and aging
Manuel Collado et al.
CELL (2007)
How stem cells age and why this makes us grow old
Norman E. Sharpless et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Molecular biology of human papillomavirus infection and cervical cancer
John Doorbar
CLINICAL SCIENCE (2006)
Overexpression of p16ink4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri
R Klaes et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Share Paper
